マイクロバイオームの世界市場2024-2028

■ 英語タイトル:Global Microbiomes Market 2024-2028

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR41199-24)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR41199-24
■ 発行日:2023年12月5日
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[マイクロバイオームの世界市場2024-2028]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

マイクロバイオームの世界市場 2024-2028マイクロバイオーム市場は2023年から2028年にかけて11億3278万米ドルの成長が予測され、予測期間中のCAGRは22.67%で加速すると予測されています。当レポートでは、マイクロバイオーム市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、疾患の有病率の増加、マイクロバイオーム研究に対する取り組みや投資の増加、マイクロバイオーム探索・治療・診断の進歩によって牽引されています。

Technavioのマイクロバイオーム市場は以下のように区分されます:
製品別
- プロバイオティクス
- 食品
- プレバイオティクス
- 医療用食品
- その他

用途別
- 治療薬
- 診断薬

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間のマイクロバイオーム市場の成長を促進する主な要因の1つとして、マイクロバイオーム治療薬開発のための多数の共同研究を挙げています。また、バイオセンサーや遺伝子回路の開発への注目の高まりや、規制の枠組みの発展も、市場の大きな需要につながるでしょう。

この調査レポートは、マイクロバイオーム市場を調査・分析した結果をまとめたものです:
- マイクロバイオーム市場の規模
- マイクロバイオーム市場の予測
- マイクロバイオーム市場の産業分析

堅牢なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AOBiome LLC, BiomX Inc., DuPont de Nemours Inc., Eligo Bioscience, ENTEROME SA, Evelo Biosciences Inc., ExeGi Pharma, Ferring BV, MaaT Pharma, OraSure Technologies Inc., Osel Inc., Pendulum Therapeutics Inc., PureTech Health Plc, Qualigen Therapeutics Inc., Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Takeda Pharmaceutical Co. Ltd., Vedanta Biosciences Inc., YSOPIA Bioscience, and THERIVA BIOLOGICS INC.などを分析しています。また、マイクロバイオーム市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場概況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 世界のマイクロバイオーム市場規模:製品別分析
7 世界のマイクロバイオーム市場規模:用途別分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global microbiomes market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global microbiomes market 2018 – 2022 ($ million)
o 4.2 Product Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Product Segment 2018 – 2022 ($ million)
o 4.3 Application Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Application Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product – Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Probiotics – Market size and forecast 2023-2028
o Exhibit 34: Chart on Probiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Probiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Probiotics – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Probiotics – Year-over-year growth 2023-2028 (%)
o 6.4 Foods – Market size and forecast 2023-2028
o Exhibit 38: Chart on Foods – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Foods – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Foods – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Foods – Year-over-year growth 2023-2028 (%)
o 6.5 Prebiotics – Market size and forecast 2023-2028
o Exhibit 42: Chart on Prebiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Prebiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Prebiotics – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Prebiotics – Year-over-year growth 2023-2028 (%)
o 6.6 Medical food – Market size and forecast 2023-2028
o Exhibit 46: Chart on Medical food – Market size and forecast 2023-2028 ($ million)
o Exhibit 47: Data Table on Medical food – Market size and forecast 2023-2028 ($ million)
o Exhibit 48: Chart on Medical food – Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Medical food – Year-over-year growth 2023-2028 (%)
o 6.7 Others – Market size and forecast 2023-2028
o Exhibit 50: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.8 Market opportunity by Product
o Exhibit 54: Market opportunity by Product ($ million)
o Exhibit 55: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 56: Chart on Application – Market share 2023-2028 (%)
o Exhibit 57: Data Table on Application – Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 58: Chart on Comparison by Application
o Exhibit 59: Data Table on Comparison by Application
o 7.3 Therapeutics – Market size and forecast 2023-2028
o Exhibit 60: Chart on Therapeutics – Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Therapeutics – Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Therapeutics – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Therapeutics – Year-over-year growth 2023-2028 (%)
o 7.4 Diagnostics – Market size and forecast 2023-2028
o Exhibit 64: Chart on Diagnostics – Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Data Table on Diagnostics – Market size and forecast 2023-2028 ($ million)
o Exhibit 66: Chart on Diagnostics – Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Diagnostics – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Application
o Exhibit 68: Market opportunity by Application ($ million)
o Exhibit 69: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 75: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 91: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 France – Market size and forecast 2023-2028
o Exhibit 99: Chart on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.10 Japan – Market size and forecast 2023-2028
o Exhibit 103: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.11 UK – Market size and forecast 2023-2028
o Exhibit 107: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 108: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 109: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AOBiome LLC
o Exhibit 119: AOBiome LLC – Overview
o Exhibit 120: AOBiome LLC – Product / Service
o Exhibit 121: AOBiome LLC – Key offerings
o 12.4 BiomX Inc.
o Exhibit 122: BiomX Inc. – Overview
o Exhibit 123: BiomX Inc. – Product / Service
o Exhibit 124: BiomX Inc. – Key offerings
o 12.5 DuPont de Nemours Inc.
o Exhibit 125: DuPont de Nemours Inc. – Overview
o Exhibit 126: DuPont de Nemours Inc. – Business segments
o Exhibit 127: DuPont de Nemours Inc. – Key news
o Exhibit 128: DuPont de Nemours Inc. – Key offerings
o Exhibit 129: DuPont de Nemours Inc. – Segment focus
o 12.6 Eligo Bioscience
o Exhibit 130: Eligo Bioscience – Overview
o Exhibit 131: Eligo Bioscience – Product / Service
o Exhibit 132: Eligo Bioscience – Key offerings
o 12.7 ENTEROME SA
o Exhibit 133: ENTEROME SA – Overview
o Exhibit 134: ENTEROME SA – Product / Service
o Exhibit 135: ENTEROME SA – Key offerings
o 12.8 Evelo Biosciences Inc.
o Exhibit 136: Evelo Biosciences Inc. – Overview
o Exhibit 137: Evelo Biosciences Inc. – Product / Service
o Exhibit 138: Evelo Biosciences Inc. – Key offerings
o 12.9 ExeGi Pharma
o Exhibit 139: ExeGi Pharma – Overview
o Exhibit 140: ExeGi Pharma – Product / Service
o Exhibit 141: ExeGi Pharma – Key offerings
o 12.10 Ferring BV
o Exhibit 142: Ferring BV – Overview
o Exhibit 143: Ferring BV – Product / Service
o Exhibit 144: Ferring BV – Key offerings
o 12.11 OraSure Technologies Inc.
o Exhibit 145: OraSure Technologies Inc. – Overview
o Exhibit 146: OraSure Technologies Inc. – Business segments
o Exhibit 147: OraSure Technologies Inc. – Key offerings
o Exhibit 148: OraSure Technologies Inc. – Segment focus
o 12.12 Osel Inc.
o Exhibit 149: Osel Inc. – Overview
o Exhibit 150: Osel Inc. – Product / Service
o Exhibit 151: Osel Inc. – Key offerings
o 12.13 PureTech Health Plc
o Exhibit 152: PureTech Health Plc – Overview
o Exhibit 153: PureTech Health Plc – Business segments
o Exhibit 154: PureTech Health Plc – Key offerings
o Exhibit 155: PureTech Health Plc – Segment focus
o 12.14 Second Genome Therapeutics
o Exhibit 156: Second Genome Therapeutics – Overview
o Exhibit 157: Second Genome Therapeutics – Product / Service
o Exhibit 158: Second Genome Therapeutics – Key offerings
o 12.15 Seres Therapeutics Inc.
o Exhibit 159: Seres Therapeutics Inc. – Overview
o Exhibit 160: Seres Therapeutics Inc. – Product / Service
o Exhibit 161: Seres Therapeutics Inc. – Key offerings
o 12.16 Synlogic Inc.
o Exhibit 162: Synlogic Inc. – Overview
o Exhibit 163: Synlogic Inc. – Product / Service
o Exhibit 164: Synlogic Inc. – Key offerings
o 12.17 THERIVA BIOLOGICS INC.
o Exhibit 165: THERIVA BIOLOGICS INC. – Overview
o Exhibit 166: THERIVA BIOLOGICS INC. – Product / Service
o Exhibit 167: THERIVA BIOLOGICS INC. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global microbiomes market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Product Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Application Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Product – Market share 2023-2028 (%)
Exhibits31: Data Table on Product – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Probiotics – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Probiotics – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Probiotics – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Probiotics – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Foods – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Foods – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Foods – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Foods – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Prebiotics – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Prebiotics – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Prebiotics – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Prebiotics – Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Medical food – Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Medical food – Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Medical food – Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Medical food – Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Product ($ million)
Exhibits55: Data Table on Market opportunity by Product ($ million)
Exhibits56: Chart on Application – Market share 2023-2028 (%)
Exhibits57: Data Table on Application – Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by Application
Exhibits59: Data Table on Comparison by Application
Exhibits60: Chart on Therapeutics – Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Therapeutics – Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Therapeutics – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Therapeutics – Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Diagnostics – Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Diagnostics – Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Diagnostics – Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Diagnostics – Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Application ($ million)
Exhibits69: Data Table on Market opportunity by Application ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on France – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on France – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AOBiome LLC – Overview
Exhibits120: AOBiome LLC – Product / Service
Exhibits121: AOBiome LLC – Key offerings
Exhibits122: BiomX Inc. – Overview
Exhibits123: BiomX Inc. – Product / Service
Exhibits124: BiomX Inc. – Key offerings
Exhibits125: DuPont de Nemours Inc. – Overview
Exhibits126: DuPont de Nemours Inc. – Business segments
Exhibits127: DuPont de Nemours Inc. – Key news
Exhibits128: DuPont de Nemours Inc. – Key offerings
Exhibits129: DuPont de Nemours Inc. – Segment focus
Exhibits130: Eligo Bioscience – Overview
Exhibits131: Eligo Bioscience – Product / Service
Exhibits132: Eligo Bioscience – Key offerings
Exhibits133: ENTEROME SA – Overview
Exhibits134: ENTEROME SA – Product / Service
Exhibits135: ENTEROME SA – Key offerings
Exhibits136: Evelo Biosciences Inc. – Overview
Exhibits137: Evelo Biosciences Inc. – Product / Service
Exhibits138: Evelo Biosciences Inc. – Key offerings
Exhibits139: ExeGi Pharma – Overview
Exhibits140: ExeGi Pharma – Product / Service
Exhibits141: ExeGi Pharma – Key offerings
Exhibits142: Ferring BV – Overview
Exhibits143: Ferring BV – Product / Service
Exhibits144: Ferring BV – Key offerings
Exhibits145: OraSure Technologies Inc. – Overview
Exhibits146: OraSure Technologies Inc. – Business segments
Exhibits147: OraSure Technologies Inc. – Key offerings
Exhibits148: OraSure Technologies Inc. – Segment focus
Exhibits149: Osel Inc. – Overview
Exhibits150: Osel Inc. – Product / Service
Exhibits151: Osel Inc. – Key offerings
Exhibits152: PureTech Health Plc – Overview
Exhibits153: PureTech Health Plc – Business segments
Exhibits154: PureTech Health Plc – Key offerings
Exhibits155: PureTech Health Plc – Segment focus
Exhibits156: Second Genome Therapeutics – Overview
Exhibits157: Second Genome Therapeutics – Product / Service
Exhibits158: Second Genome Therapeutics – Key offerings
Exhibits159: Seres Therapeutics Inc. – Overview
Exhibits160: Seres Therapeutics Inc. – Product / Service
Exhibits161: Seres Therapeutics Inc. – Key offerings
Exhibits162: Synlogic Inc. – Overview
Exhibits163: Synlogic Inc. – Product / Service
Exhibits164: Synlogic Inc. – Key offerings
Exhibits165: THERIVA BIOLOGICS INC. – Overview
Exhibits166: THERIVA BIOLOGICS INC. – Product / Service
Exhibits167: THERIVA BIOLOGICS INC. – Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR41199-24 )"マイクロバイオームの世界市場2024-2028" (英文:Global Microbiomes Market 2024-2028)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。